Qingrui S. Huang

CAS Key Laboratory Of Microbial Physiological And Metabolic Engineering
Beijing, 100101, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Development of a Trivalent Seasonal Influenza Vaccine Using Long α-Helix-Mediated Trimeric HA1 Proteins Produced in Baculovirus-Insect Cell System.

Development of a Trivalent Seasonal Influenza Vaccine Using Long α-Helix-Mediated Trimeric HA1 Proteins Produced in Baculovirus-Insect Cell System.

Journal: MedComm

Published: December 10, 2025

Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection.

Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection.

Journal: Nature communications

Published: October 16, 2024

mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization.

mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization.

Journal: Cell host & microbe

Published: October 14, 2024

Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action.

Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action.

Journal: Nature communications

Published: September 05, 2024

A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine.

A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine.

Journal: International journal of biological macromolecules

Published: August 27, 2024

Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.

Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.

Journal: Emerging microbes & infections

Published: April 18, 2023

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.

Journal: Biosafety and health

Published: January 04, 2023

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies.

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies.

Journal: Emerging microbes & infections

Published: September 15, 2022

A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.

A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.

Journal: EBioMedicine

Published: June 27, 2022

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine.

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine.

Journal: Science bulletin

Published: February 16, 2022

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants.

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants.

Journal: Signal transduction and targeted therapy

Published: December 29, 2021

Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice.

Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice.

Journal: Cell discovery

Published: June 10, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026